Companies: 10,795·Total market cap: $144.5T
Illumina, Inc.

Illumina, Inc.

ILMNNASDAQHealthcare● Active
$157.23
$-5.10(-3.14%)
Market Cap$23.8B
P/E Ratio—
52W High$172.49
52W Low$81.76
Overview

Illumina, Inc. (ILMN) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ILMN · cash on hand · updated Dec 28, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$1.63B▲ +33.9% vs prior year
FY · as of Dec 28, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$1.42B
cashAndCashEquivalents
Short-Term Investments
$215.0M
shortTermInvestments
YoY Change vs Prior Year
+33.9%
vs prior fiscal year
Latest Quarter
$1.16B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 28, 2025

Net cash vs debt

Cash & ST Investments$1.63BCash on Hand
Total Debt$2.55BTotal Debt
Net Cash / Net Debt−$920.0MNet Debt Position
Cash vs Debt Ratio
Cash 39%Debt 61%

Illumina, Inc. carries a net debt position of $920.0M. Total debt ($2.55B) exceeds cash on hand ($1.63B). Illumina, Inc. cash vs debt ratio: 39% cash / 61% debt.

Net Cash = Cash & ST Investments − Total Debt$1.63B − $2.55B = −$920.0M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
ILMN annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 28, 2025Latest$1.63B+33.9%
Dec 29, 2024$1.22B+15.7%
Dec 31, 2023$1.05B-48.3%
Jan 1, 2023$2.04B+52.1%
Jan 2, 2022$1.34B-61.4%
ILMN cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Illumina, Inc.
Illumina, Inc.YOU
ILMN
$1.63B6.9%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Illumina, Inc. (ILMN) cash on hand as of December 28, 2025 is $1.63B, comprising $1.42B in cash and cash equivalents (CCE) plus $215.0M in short-term investments — reported as Illumina, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Illumina, Inc. cash reserves or cash position.

Illumina, Inc. annual cash on hand history shows increased +33.9% in 2025: increased +33.9% in 2025. Illumina, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Illumina, Inc. carries total debt of $2.55B against cash of $1.63B, resulting in a net debt position of -$920.0M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

ILMN cash on hand · 5 questions

As of December 28, 2025, Illumina, Inc. (ILMN) has $1.63B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $1.42B in cash and cash equivalents (CCE) plus $215,000,000 in short-term investments. Latest quarter (March 29, 2026): $1.16B. Data sourced from the annual 10-K filing via FMP.

ILMN cash on handILMN cash reservesILMN cash 2025how much cash does ILMN have

▸ Source: FMP /balance-sheet-statement · US GAAP · Illumina, Inc. · Illumina, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 28, 2025